Century Therapeutics presents preclinical data for type 1 diabetes therapy

June 8, 2026 4:05 PM

Century Therapeutics Inc. (NASDAQ: IPSC) presented preclinical data for CNTY-813, its induced pluripotent stem cell-derived islet replacement therapy for type ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found